Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 54 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 10/22/2008 First Published: 12/23/2003


1.		Phase III Randomized Study of Dexamethasone Versus Prednisone During Induction and High-Dose Methotrexate With Leucovorin Rescue Versus Escalating-Dose Methotrexate Without Leucovorin Rescue During Interim Maintenance I in Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				1 to under 31				NCI				COG-AALL0232 NCT00075725, AALL0232

Last Modified: 10/22/2008 First Published: 11/22/2006


2.		Phase III Randomized Study of Augmented Berlin-Frankfurt-Münster-86 Multiagent Chemotherapy, Intensified Methotrexate, and Nelarabine in Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				1 to under 31				NCI				COG-AALL0434 AALL0434, NCT00408005


3.		Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				66 and over				NCI, NHLBI				418 BMTCTN-0201, NCT00075816


4.		A Study of Actonel for the Prevention of Bone Loss

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				18 and over				Other				ID03-0124 NCT00452439


5.		Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				15 and over				Other				2004-0107 NCT00500240


6.		A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				CP4055-106 NCT00405743


7.		Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				AT9283/0002 2006-0177, NCT00522990


8.		Phase I/II Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				60 and under				Other				UMCC 2007.055 NCT00556452


9.		A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				CLBH589B2102 NCT00621244


10.		Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				0 to 55				Other				8717 NCT00673114

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute